{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:22:32Z","timestamp":1791199352838,"version":"4.1.0"},"reference-count":36,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.3892\/ijo.2015.2943","type":"journal-article","created":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T10:01:57Z","timestamp":1427882517000},"page":"2497-2505","source":"Crossref","is-referenced-by-count":114,"title":["Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion\/metastasis in serous ovarian cancer"],"prefix":"10.3892","volume":"46","author":[{"given":"JUN-JUN","family":"QIU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YING-YING","family":"LIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JING-XIN","family":"DING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEI-WEI","family":"FENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HONG-YAN","family":"JIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KE-QIN","family":"HUA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,3,31]]},"reference":[{"key":"key20180107184237_b1-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"key20180107184237_b2-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc2946","article-title":"The genesis and evolution of high-grade serous ovarian cancer","volume":"10","author":"Bowtell","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"key20180107184237_b3-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"367103","DOI":"10.1155\/2014\/367103","article-title":"Molecular profiling and clinical outcome of high-grade serous ovarian cancer presenting with low- versus high-volume ascites","volume":"2014","author":"Feigenberg","year":"2014","journal-title":"Biomed Res Int"},{"key":"key20180107184237_b4-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"key":"key20180107184237_b5-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0140-6736(11)60126-8","article-title":"Early versus delayed treatment of relapsed ovarian cancer","volume":"377","author":"Rustin","year":"2011","journal-title":"Lancet"},{"key":"key20180107184237_b6-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1101\/gad.1800909","article-title":"Long noncoding RNAs: Functional surprises from the RNA world","volume":"23","author":"Wilusz","year":"2009","journal-title":"Genes Dev"},{"key":"key20180107184237_b7-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cell.2011.03.014","article-title":"No-nonsense functions for long noncoding RNAs","volume":"145","author":"Nagano","year":"2011","journal-title":"Cell"},{"key":"key20180107184237_b8-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08975","article-title":"Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis","volume":"464","author":"Gupta","year":"2010","journal-title":"Nature"},{"key":"key20180107184237_b9-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","article-title":"The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells","volume":"73","author":"Gutschner","year":"2013","journal-title":"Cancer Res"},{"key":"key20180107184237_b10-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/hep.25895","article-title":"Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients\u2019 poor recurrence-free survival after hepatectomy","volume":"56","author":"Yuan","year":"2012","journal-title":"Hepatology"},{"key":"key20180107184237_b11-ijo-46-06-2497","first-page":"2695","article-title":"DD3(PCA3), a very sensitive and specific marker to detect prostate tumors","volume":"62","author":"de Kok","year":"2002","journal-title":"Cancer Res"},{"key":"key20180107184237_b12-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s13277-013-1142-z","article-title":"Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer","volume":"35","author":"Sun","year":"2014","journal-title":"Tumour Biol"},{"key":"key20180107184237_b13-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/hep.26740","article-title":"Long noncoding RNA HOTTIP\/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients","volume":"59","author":"Quagliata","year":"2014","journal-title":"Hepatology"},{"key":"key20180107184237_b14-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12032-013-0588-6","article-title":"Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer","volume":"30","author":"Ge","year":"2013","journal-title":"Med Oncol"},{"key":"key20180107184237_b15-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1158\/1078-0432.CCR-06-0134","article-title":"Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma","volume":"12","author":"Wang","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107184237_b16-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fgene.2012.00219","article-title":"Long non-coding RNAs in cancer progression","volume":"3","author":"Tano","year":"2012","journal-title":"Front Genet"},{"key":"key20180107184237_b17-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature06468","article-title":"Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA","volume":"451","author":"Yu","year":"2008","journal-title":"Nature"},{"key":"key20180107184237_b18-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nsmb.1824","article-title":"Role for the MOV10 RNA helicase in polycomb-mediated repression of the INK4a tumor suppressor","volume":"17","author":"El Messaoudi-Aubert","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"key20180107184237_b19-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1158\/0008-5472.CAN-06-2004","article-title":"Characterization of a germ-line deletion, including the entire INK4\/ARF locus, in a melanoma-neural system tumor family: Identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF","volume":"67","author":"Pasmant","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107184237_b20-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/onc.2010.568","article-title":"Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene","volume":"30","author":"Kotake","year":"2011","journal-title":"Oncogene"},{"key":"key20180107184237_b21-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.molcel.2010.03.021","article-title":"Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a","volume":"38","author":"Yap","year":"2010","journal-title":"Mol Cell"},{"key":"key20180107184237_b22-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ng.586","article-title":"Breast Cancer Susceptibility Collaboration (UK): Genome-wide association study identifies five new breast cancer susceptibility loci","volume":"42","author":"Turnbull","year":"2010","journal-title":"Nat Genet"},{"key":"key20180107184237_b23-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1158\/1078-0432.CCR-06-2319","article-title":"Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians","volume":"13","author":"Chen","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107184237_b24-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ng.601","article-title":"A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci","volume":"42","author":"Bei","year":"2010","journal-title":"Nat Genet"},{"key":"key20180107184237_b25-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ng.412","article-title":"New common variants affecting susceptibility to basal cell carcinoma","volume":"41","author":"Stacey","year":"2009","journal-title":"Nat Genet"},{"key":"key20180107184237_b26-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00439-012-1212-0","article-title":"Genome-wide association study of glioma and meta-analysis","volume":"131","author":"Rajaraman","year":"2012","journal-title":"Hum Genet"},{"key":"key20180107184237_b27-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ng.585","article-title":"Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk","volume":"42","author":"Sherborne","year":"2010","journal-title":"Nat Genet"},{"key":"key20180107184237_b28-ijo-46-06-2497","first-page":"891","article-title":"Enhanced c-erbB-2\/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A","volume":"53","author":"Yu","year":"1993","journal-title":"Cancer Res"},{"key":"key20180107184237_b29-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1525-1438.2006.00296.x","article-title":"Analysis of gene expression patterns of ovarian cancer cell lines with different metastatic potentials","volume":"16","author":"Bai","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"key20180107184237_b30-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1631\/jzus.B1000192","article-title":"Up-regulation of mitochondrial antioxidation signals in ovarian cancer cells with aggressive biologic behavior","volume":"12","author":"Wang","year":"2011","journal-title":"J Zhejiang Univ Sci B"},{"key":"key20180107184237_b31-ijo-46-06-2497","first-page":"233","article-title":"Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization","volume":"18","author":"Shenhua","year":"1999","journal-title":"J Exp Clin Cancer Res"},{"key":"key20180107184237_b32-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/j.gastro.2006.08.026","article-title":"Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA","volume":"132","author":"Panzitt","year":"2007","journal-title":"Gastroenterology"},{"key":"key20180107184237_b33-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"26302","DOI":"10.1074\/jbc.M112.342113","article-title":"Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18","volume":"287","author":"Du","year":"2012","journal-title":"J Biol Chem"},{"key":"key20180107184237_b34-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2011.11.017","article-title":"Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A\/B","volume":"220","author":"Congrains","year":"2012","journal-title":"Atherosclerosis"},{"key":"key20180107184237_b35-ijo-46-06-2497","first-page":"701","article-title":"ANRIL is implicated in the regulation of nucleus and potential transcriptional target of E2F1","volume":"24","author":"Sato","year":"2010","journal-title":"Oncol Rep"},{"key":"key20180107184237_b36-ijo-46-06-2497","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.bbrc.2012.02.050","article-title":"CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC","volume":"419","author":"Congrains","year":"2012","journal-title":"Biochem Biophys Res Commun"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2015.2943\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T13:46:10Z","timestamp":1515332770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2015.2943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,31]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,3,31]]},"published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.3892\/ijo.2015.2943"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2015.2943","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,31]]}}}